心室重构与骨桥蛋白

王蕊; 周桂桐; 魏冰; 姜希娟

doi:10.13201/j.issn.1001-1439.2016.10.021

心室重构与骨桥蛋白

- 天津中医药大学(天津, 300193)
基金项目:
国家自然科学基金(No:81573733)

详细信息

通讯作者: 姜希娟,E-mail:1371409370@qq.com

中图分类号: R541.6

收稿日期: 2016-01-19

修回日期: 2016-03-18

Ventricular remodeling and Osteopontin

- Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China

More Information

Corresponding author: JIANG Xijuan, E-mail: 1371409370@qq.com

Received Date: 19 January 2016

Revised Date: 18 March 2016

摘要

摘要: 心室重构被认为是导致心力衰竭不断进展的病理生理机制。近期研究表明,骨桥蛋白与心室重构的发生发展密切相关。认识心室重构与骨桥蛋白的关系,对于心肌梗死、动脉粥样硬化、心力衰竭等多种心血管疾病的诊治具有重要的意义。
- 心室重构 /
- 骨桥蛋白 /
- 心力衰竭
Abstract: Ventricular remodeling is thought to be the pathological and physiological basis of constant progress of heart failure.Recent studies have shown that osteopontin is closely related to the occurrence and development of ventricular remodeling.Understanding the relationship between ventricular remodeling and osteopontin,has the vital significance for diagnosis and treatment of myocardial infarction,atherosclerosis,heart failure and other cardiovascular diseases.This article will review the relationship between ventricular remodeling and osteopontin.
- ventricular remodeling /
- osteopontin /
- heart failure

HTML全文

参考文献(19)

[1]	姚震,陈林.我国心血管疾病现状与展望[J].海南医学,2013,24(13):1873-1876.
[2]	金惠铭,王建枝.病理生理学[M].7版.北京:人民卫生出版社,2008:204-206.
[3]	XIE M,BURCHFIELD J S,HILL J A.Pathological ventricular remodeling:Mechanisms:Part 1of 2[J].Circulation,2013,128:388-400.
[4]	付学国.心室重塑的形成和治疗[J].青海医药杂志,2010,40(4):72-74.
[5]	王爱民,王立君.心室重塑的研究进展[J].疑难病杂志,2008,7(2):123-124.
[6]	丁凤云.心室重塑及心衰[J].卫生职业教育,2006,24(23):130-131.
[7]	SCHERRER-CROSBIE M,KURTZ B.Ventricular remodeling and function:insights using murine echocardiography[J].J Mol Cell Cardiol,2010,48:512-517.
[8]	O'REGAN D P,SHI W Z,ARIFF B,et al.Remodeling after acute myocardial infarction:mapping ventricular dilatation using three dimensional CMR image registration[J].J Cardiovasc Magn Reson,2012,14:1-9.
[9]	刘灿君.GDF-15与心肌梗死后心室重塑指标的相关性分析[J].心血管康复医学杂志,2014,23(4):408-411.
[10]	KAZANECKI CC,UZWIAK DJ,DENHARDT DT.Control of osteopontin signaling and function by posttranslational phosphorylation and protein folding[J].JCell Biochem,2007,102:912-924.
[11]	SCHIPPER ME,SCHEENSTRA MR,KUIK J,et al.Osteopontin:apotential biomarker for heart failure and reverse remodeling after left ventricular assist devicesupport[J].J Heart Lung Transplant,2011,30:805-810.
[12]	孟磊,王洁,丁文惠,等.急性心肌梗死患者血浆骨桥蛋白变化与左心室重构[J/OL].http://www.cnki.net/kcms/detail/11.4691.R.20130530.0850.005.html,2013-05-30.
[13]	TRUEBLOOD N A,XIE Z L,COMMUNAL C,et al.Exaggerated left ventrieular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin[J].Circ Res,2001,88:1080-1087.
[14]	KRISHNAMURTHY P,PETERSON J T,SUBRA-MANIAN V,et al.Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction[J].Mol Cell Biochem,2009,322:53-62.
[15]	PSARRAS S,MAVROIDIS M,SANOUDOU D,et al.Regulation of adverse remodelling by osteopontin in a genetic heart failure model.Eur Heart J,2012,33:1954-1963.
[16]	MENON B,SINGH M,SINGH M.Matrix metalloproteinases mediate-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes[J].Am JPhysiol Cell Physiol,2005,289:168-176.
[17]	SINGH M,FOSTER C R,DALAL S,et al.Osteopontin:role in extracellular matrix deposition and myocardial remodeling post-MI[J].J Mol Cell Cardiol,2010,48:538-543.
[18]	ZHAO X,JOHNSON J N,SINGH K,et al.Impairment of myocardial angiogenic response in the absence of osteopontin[J].Microcirculation,2007,14:233-240.
[19]	朱永芝,胡信群.骨桥蛋白在心肌梗死后心力衰竭中研究进展[J].医学与哲学,2014,35(513):68-70.